
Enable job alerts via email!
A leading contract research organization is seeking a Business Development Executive to join their Discovery and Safety Assessment unit. This is a fully remote role with expected travel of 25%–50%. The position requires a strong background in life sciences and proven sales experience, emphasizing building client relationships and achieving sales targets. The company offers a comprehensive benefits package to support your career growth and well-being.
For 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
Business Development Executive role on a full-time, permanent basis to join our Discovery and Safety Assessment (DSA) business unit. This is a fully remote role, with expectation for 25%–50% travel to client sites or external conferences to represent Charles River.
The Business Development Executive will primarily focus on securing new business for Discovery and Safety Assessment, aiming to achieve quarterly and annual sales booking targets while maintaining an existing client base. You’ll be an expert at building and fostering strong working relationships, able to apply scientific know-how in securing client trust and generating new business leads.
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 350 patents and 80 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification through IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges and move us forward together on the journey of getting new drugs to market.
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, GLP and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. This broad portfolio enables a flexible drug development model that reduces costs and increases speed to market.
With over 20,000 employees in 110 facilities across 20 countries, we coordinate worldwide resources and apply multidisciplinary perspectives to resolve our clients’ challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies, hospitals and academic institutions.
At Charles River, we are passionate about improving the quality of people’s lives. Our mission, excellent science, and strong sense of purpose guide us in all we do, and we approach each day knowing our work helps improve health and well-being globally. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
At Charles River Laboratories, we recognize and recruit all talent. We are a company committed to diversity and inclusion and work daily toward this direction.